Associations between initiating antihypertensive regimens on stage I–III colorectal cancer outcomes: A Medicare SEER cohort analysis
R Balkrishnan, RP Desai, A Narayan… - Cancer …, 2021 - Wiley Online Library
… that, the treatment pathway presents a very effective first-line … effect of treatment with
bevacizumab is arterial hypertension, … cancer mortality, though the correlation with hypertension …
bevacizumab is arterial hypertension, … cancer mortality, though the correlation with hypertension …
Targeted therapies in the management of colorectal carcinoma: role of bevacizumab
… Several studies have shown that VEGF levels correlate with increased micro vessel density,
… determine the value of bevacizumab continuation after bevacizumab-first line progression. …
… determine the value of bevacizumab continuation after bevacizumab-first line progression. …
[HTML][HTML] Predictive biomarkers candidates for patients with metastatic colorectal cancer treated with bevacizumab-containing regimen
N González-Vacarezza, I Alonso, G Arroyo… - Drug Metabolism and …, 2016 - degruyter.com
… consecutive mCRC patients treated with a first-line FOLFIRI plus bevacizumab. … correlate
with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab …
with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab …
Evaluation of hypertension and proteinuria as markers of efficacy in antiangiogenic therapy for metastatic colorectal cancer
L Khoja, G Kumaran, YK Zee, N Murukesh… - Journal of clinical …, 2014 - journals.lww.com
… (mCRC) as first-line or second-line therapy. More recently the … with bevacizumab or
VEGF receptor TKI are associated with … There was no significant correlation between the …
VEGF receptor TKI are associated with … There was no significant correlation between the …
Observational cohort study of patients with metastatic colorectal cancer initiating chemotherapy in combination with bevacizumab (CONCERT)
… bevacizumab (Avastin) combined with first-line chemotherapy for patients with metastatic
colorectal cancer (… , BRiTE (Bevacizumab Regimens: Investigation of Treatment Effects and …
colorectal cancer (… , BRiTE (Bevacizumab Regimens: Investigation of Treatment Effects and …
Effect of bevacizumab in combination with standard oxaliplatin-based regimens in patients with metastatic colorectal cancer: a randomized clinical trial
A Avallone, MC Piccirillo, G Nasti, G Rosati… - JAMA Network …, 2021 - jamanetwork.com
… Assuming an ORR of 40% in the first line and 20% in the second line, an anticipated odds
… The number of BRAF-altered tumors was too small to allow correlation with outcomes. The …
… The number of BRAF-altered tumors was too small to allow correlation with outcomes. The …
[HTML][HTML] Role of arterial hypertension as a predictive marker for bevacizumab efficacy in recurrent glioblastoma–a prospective analysis
CC Wagner, U Held, R Kofmehl, E Battegay… - Acta …, 2014 - Taylor & Francis
… (n = 53) [Citation6], colorectal carcinoma (n = 39 and n = 181) [Citation7,Citation8] and …
start of bevacizumab. Our definition correlates to an at least grade 2 hypertension according to …
start of bevacizumab. Our definition correlates to an at least grade 2 hypertension according to …
Relationship between safety and cumulative bevacizumab dose in patients with metastatic colorectal cancer who received long-term bevacizumab treatment
S Fukuda, Y Niisato, M Tsuji, S Fukuda… - Anticancer …, 2023 - ar.iiarjournals.org
… progression-free survival time with first-line chemotherapy, including bevacizumab, is 8-15 …
dose of bevacizumab was correlated with the risk of developing proteinuria and hypertension, …
dose of bevacizumab was correlated with the risk of developing proteinuria and hypertension, …
[HTML][HTML] Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients' survival
A Ottaiano, M Santorsola, L Circelli, F Perri… - Frontiers in …, 2023 - frontiersin.org
… Interestingly, we found that diabetic patients are less prone to respond to first-line … correlation
was revealed in patients experiencing BIH with response to bevacizumab-based first-line …
was revealed in patients experiencing BIH with response to bevacizumab-based first-line …
Basal proteinuria as a prognostic factor in patients with metastatic colorectal cancer treated with bevacizumab
… This study investigated the correlation of the clinical benefits … ) by the addition of bevacizumab
to the first-line therapy, … , and increased arterial blood pressure during treatment may be …
to the first-line therapy, … , and increased arterial blood pressure during treatment may be …